###begin article-title 0
TRIM5alpha selectively binds a restriction-sensitive retroviral capsid
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
TRIM5 is a potent retrovirus inhibitor that targets viruses bearing particular capsid (CA) residues. In most primate species, retroviral restriction requires the C-terminal SPRY domain unique to the alpha-isoform of TRIM5, but the mechanism by which susceptible viruses are recognized and targeted for restriction is unknown. Here we show that TRIM5alpha binds retroviral CA from detergent-stripped virions in a SPRY-dependent manner with sufficient discrimination to account for the exquisite specificity of restriction.
###end p 2
###begin title 3
Findings
###end title 3
###begin p 4
###xml 144 145 144 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 146 147 146 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 372 373 372 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 374 375 374 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 503 504 499 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 505 506 501 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 507 508 503 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 553 555 549 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 831 832 815 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 833 835 817 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 836 838 820 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 235 245 <span type="species:ncbi:9505">owl monkey</span>
###xml 252 257 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 411 417 <span type="species:ncbi:9606">humans</span>
Two independent screens identified TRIM5 as a potent retrovirus restriction element that targets select viruses after entry into primate cells [1,2]. The biochemical basis for specificity of restriction is only evident in cells of the owl monkey where HIV-1 CA is recognized by the C-terminal cyclophilin domain that is unique to the TRIM5 orthologue found in this genus [2-4]. In all other primates, including humans and macaques, potent CA-specific restriction is conferred by the TRIM5alpha isoform [1,5-9], which possesses a C-terminal SPRY domain [10]. The mechanism by which TRIM5alpha selects retroviruses bearing particular CAs for restriction is unknown, though the TRIM5alpha SPRY domain is required for restriction and variation in SPRY amino acid residues determines the CA-specificity of given TRIM5alpha orthologues [9,11-13].
###end p 4
###begin p 5
###xml 239 241 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 325 327 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 328 330 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 509 512 497 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gag</italic>
###xml 514 521 502 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gag-pol</italic>
###xml 526 530 514 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gag </italic>
###xml 509 512 <span type="species:ncbi:103820">gag</span>
###xml 514 517 <span type="species:ncbi:103820">gag</span>
Conventional biochemical and two-hybid experiments failed to detect an interaction between TRIM5alpha and CA (SS and JL, unpublished data). The observation that non-infectious virus-like particles saturate TRIM5alpha-mediated restriction [14], but only if the particles bear a mature core from a restriction-sensitive virus [15,16] suggests that the TRIM5alpha SPRY domain recognizes a complex structure unique to the core of susceptible virions. Consistent with this model, expression within target cells of gag, gag-pol, or gag fragments encoding CA, CA-NC, or ubiquitin-CA-NC fusions, failed to block restriction activity (David Sayah and JL, unpublished data).
###end p 5
###begin p 6
###xml 82 84 82 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 323 324 323 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 325 326 325 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 87 92 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 270 280 <span type="species:ncbi:9505">owl monkey</span>
###xml 361 366 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 386 400 <span type="species:ncbi:9544">rhesus macaque</span>
Retrovirion cores can be liberated from the viral membrane envelope by detergent [17]. HIV-1 virion cores were prepared with several different detergents and mixed with recombinant TRIM5 orthologues. After TRIM5 enrichment by affinity chromatography, CA associated with owl monkey TRIMCypA, as reported with other methods [3,4], but not with the equally potent HIV-1 restriction factor rhesus macaque TRIM5alpha (SS and JL, unpublished data).
###end p 6
###begin p 7
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 188 190 188 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 423 424 419 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 425 426 421 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 17 38 <span type="species:ncbi:11786">murine leukemia virus</span>
###xml 40 43 <span type="species:ncbi:11786">MLV</span>
###xml 76 81 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 83 86 <span type="species:ncbi:11786">MLV</span>
###xml 193 196 <span type="species:ncbi:11786">MLV</span>
###xml 256 259 <span type="species:ncbi:11786">MLV</span>
###xml 302 307 <span type="species:ncbi:9606">human</span>
###xml 327 330 <span type="species:ncbi:11786">MLV</span>
###xml 377 380 <span type="species:ncbi:11786">MLV</span>
We then selected murine leukemia virus (MLV) for study because, relative to HIV-1, MLV CA remains tightly associated with viral reverse transcription (RT) and preintegration complexes [18,19]. MLV strains bearing an arginine at CA residue 110 (so-called N-MLV) are highly susceptible to restriction by human TRIM5alpha whereas MLV virions bearing glutamate in this position (B-MLV) are completely resistant to restriction [5-8].
###end p 7
###begin p 8
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 133 143 133 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus dunni </italic>
###xml 226 228 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 437 439 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 509 511 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 661 663 645 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 34 37 <span type="species:ncbi:11786">MLV</span>
###xml 133 142 <span type="species:ncbi:254704">Mus dunni</span>
###xml 152 155 <span type="species:ncbi:11786">MLV</span>
###xml 200 203 <span type="species:ncbi:11786">MLV</span>
###xml 243 248 <span type="species:ncbi:9606">human</span>
###xml 342 345 <span type="species:ncbi:11786">MLV</span>
###xml 372 375 <span type="species:ncbi:11786">MLV</span>
###xml 455 458 <span type="species:ncbi:11786">MLV</span>
VSV G-pseudotyped N- and B-tropic MLV virions were produced as previously described [20] and, after normalization on non-restrictive Mus dunni cells, N-MLV was roughly 100-fold less infectious than B-MLV on HeLa cells (Figure 1A). Full-length human TRIM5alpha was then produced as a GST-fusion protein in 293T cells and mixed with purified N-MLV virions. CAp30, the major MLV core protein constituent, associated with TRIM5alpha (Figure 1B). CAp30 from B-MLV virions did not associate with TRIM5alpha (Figure 1B) demonstrating that TRIM5alpha binding was specific for restriction-sensitive CA. CAp30 did not associate with TRIM5 lacking the SPRY domain (Figure 1B), indicating that the SPRY-domain is required for CA-recognition.
###end p 8
###begin p 9
###xml 211 221 207 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus dunni </italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 42 45 <span type="species:ncbi:11786">MLV</span>
###xml 124 127 <span type="species:ncbi:11786">MLV</span>
###xml 211 220 <span type="species:ncbi:254704">Mus dunni</span>
###xml 602 605 <span type="species:ncbi:11786">MLV</span>
###xml 611 614 <span type="species:ncbi:11786">MLV</span>
###xml 784 788 <span type="species:ncbi:9925">goat</span>
###xml 794 797 <span type="species:ncbi:11786">MLV</span>
###xml 928 931 <span type="species:ncbi:11786">MLV</span>
Human TRIM5alpha binds CA from restricted MLV virions. (A) HeLa cells were infected with VSV G-pseudotyped, N- and B-tropic MLV-GFP vectors after normalization for RT activity and infectivity on non-restrictive Mus dunni tail fibroblasts. The percentage of infected (GFP-positive) cells was determined by flow cytometry. (B) 293T cells were transfected with plasmids encoding glutathione S-transferase (GST) fusions with full-length TRIM5alpha or with TRIM5 lacking the SPRY domain. Cells were lysed (50 mM Tris pH 8.0, 150 mM NaCl, 1% NP-40, 0.1% SDS) and mixed for 2 hrs at 4degreesC with virions (N-MLV or B-MLV) that had been concentrated by acceleration through 25% sucrose. GST fusions and associated proteins were enriched on glutathione-sepharose beads and immunoblotted with goat anti-MLV CA antibody (CA pull-out), or anti-GST antibody (bottom panel). Unbound CA remaining in the binding reaction was probed with anti-MLV CA antibody (CA input). TRIM5 protein domains fused to GST are indicated schematically on the bottom left: RF, ring finger; BB, B box; CC, coiled-coil.
###end p 9
###begin p 10
###xml 448 449 436 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 622 627 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 641 647 <span type="species:ncbi:9606">people</span>
Retroviral restriction specificity thus seems to be determined by TRIM5alpha binding to CA in a process that requires the SPRY domain. The fact that TRIM5alpha recognized retroviral CA presented by detergent-stripped virion cores, but not free CA protein, suggests that the SPRY domain recognizes a complex surface of multimerized CA. Once cores of restriction-sensitive viruses are singled out by the SPRY domain, TRIM5alpha blocks retroviral RT [1] by a mechanism that awaits elucidation. Our findings bring us one step closer to understanding how the potent antiviral activity of TRIM5alpha might be harnessed to block HIV-1 infection in people.
###end p 10
###begin title 11
List of abbreviations
###end title 11
###begin p 12
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 7 35 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 37 40 <span type="species:ncbi:11786">MLV</span>
###xml 42 63 <span type="species:ncbi:11786">murine leukemia virus</span>
HIV-1, human immunodeficiency virus; MLV, murine leukemia virus; TRIM, tripartite motif protein; RT, reverse transcriptase; CA, retroviral capsid protein; GST, glutathione S-transferase; RF, ring finger domain; BB, B box domain; CC, coiled-coil domain.
###end p 12
###begin title 13
Competing interests
###end title 13
###begin p 14
The author(s) declare that they have no competing interests.
###end p 14
###begin title 15
Authors' contributions
###end title 15
###begin p 16
SS and JL conceived the experiments and wrote the manuscript. SS performed the laboratory work. Both authors read and approved the final manuscript.
###end p 16
###begin title 17
Acknowledgements
###end title 17
###begin p 18
This work was supported by NIH grant AI 36199 to J.L.
###end p 18
###begin article-title 19
###xml 52 57 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys
###end article-title 19
###begin article-title 20
###xml 53 63 <span type="species:ncbi:9505">owl monkey</span>
###xml 78 83 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1
###end article-title 20
###begin article-title 21
###xml 46 56 <span type="species:ncbi:9505">owl monkey</span>
###xml 83 88 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1
###end article-title 21
###begin article-title 22
###xml 14 19 <span type="species:ncbi:9606">human</span>
Disruption of human TRIM5alpha antiviral activity by nonhuman primate orthologues
###end article-title 22
###begin article-title 23
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 14 34 <span type="species:ncbi:9534">African green monkey</span>
The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities
###end article-title 23
###begin article-title 24
Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha
###end article-title 24
###begin article-title 25
###xml 34 39 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 44 65 <span type="species:ncbi:11786">murine leukemia virus</span>
Trim5alpha protein restricts both HIV-1 and murine leukemia virus
###end article-title 25
###begin article-title 26
###xml 52 75 <span type="species:ncbi:11786">murine leukemia viruses</span>
###xml 79 84 <span type="species:ncbi:9606">human</span>
TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells
###end article-title 26
###begin article-title 27
Retrovirus restriction by TRIM5alpha variants from old world and new world primates
###end article-title 27
###begin article-title 28
SPRY domains in ryanodine receptors (Ca(2+)-release channels)
###end article-title 28
###begin article-title 29
###xml 49 54 <span type="species:ncbi:9606">human</span>
###xml 75 80 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction
###end article-title 29
###begin article-title 30
Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain
###end article-title 30
###begin article-title 31
###xml 95 100 <span type="species:ncbi:9606">Human</span>
Species-Specific Variation in the B30.2(SPRY) Domain of TRIM5{alpha} Determines the Potency of Human Immunodeficiency Virus Restriction
###end article-title 31
###begin article-title 32
###xml 45 50 <span type="species:ncbi:9606">human</span>
Abrogation of Ref1 retrovirus restriction in human cells
###end article-title 32
###begin article-title 33
###xml 52 57 <span type="species:ncbi:9606">human</span>
###xml 62 91 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism
###end article-title 33
###begin article-title 34
###xml 43 48 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors
###end article-title 34
###begin article-title 35
###xml 64 99 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Biochemical and structural analysis of isolated mature cores of human immunodeficiency virus type 1
###end article-title 35
###begin article-title 36
A nucleoprotein complex mediates the integration of retroviral DNA
###end article-title 36
###begin article-title 37
###xml 69 98 <span type="species:ncbi:11801">Moloney murine leukemia virus</span>
Characterization of intracellular reverse transcription complexes of Moloney murine leukemia virus
###end article-title 37
###begin article-title 38
A conserved mechanism of retrovirus restriction in mammals
###end article-title 38

